ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ACOG vs TMO // PIOTROSKI F-SCORE QUALITY

Alpha Cognition Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ACOG 1 — TMO 8
▲ PIOTROSKI F-SCORE QUALITY LEADER: TMO
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACOG VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ACOG TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 94.10% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 9.30% -44.30 TMO /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield -10.33% 2.40% -12.73 TMO /fcf-yield <GO>
Operating Margin -60.00% 17.40% -77.40 TMO /operating-margins <GO>
Net Profit Margin -60.00% 15.10% -75.10 TMO /net-margins <GO>
Revenue Growth (YoY) — 3.90% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.52 4.50 +1.02 ACOG /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 3/9 8/9 -5.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 57.2 62.9 -5.70 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $200.1M $262.22B -$262.02B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ACOG REV TMO REV ACOG GROSS % TMO GROSS % ACOG FCF TMO FCF
FY 2025 $10.2M $44.56B 94.1% — -$20.7M $6.29B
FY 2024 $0 $42.88B — — -$7.8M $7.27B
FY 2023 $0 $42.86B — — -$8.8M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACOG // BETA —
TMO // BETA 0.94